Moors & Cabot’s Cigna CI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.43M | Sell |
9,124
-89
| -1% | -$24.6K | 0.1% | 179 |
|
|
2025
Q4 | $2.54M | Buy |
9,213
+101
| +1% | +$28.3K | 0.11% | 177 |
|
|
2025
Q3 | $2.63M | Sell |
9,112
-1,600
| -15% | -$473K | 0.11% | 168 |
|
|
2025
Q2 | $3.54M | Buy |
10,712
+1,567
| +17% | +$505K | 0.16% | 123 |
|
|
2025
Q1 | $3.01M | Sell |
9,145
-271
| -3% | -$81.6K | 0.15% | 133 |
|
|
2024
Q4 | $2.6M | Sell |
9,416
-499
| -5% | -$159K | 0.12% | 150 |
|
|
2024
Q3 | $3.43M | Sell |
9,915
-11
| -0.1% | -$3.79K | 0.17% | 117 |
|
|
2024
Q2 | $3.28M | Buy |
9,926
+73
| +0.7% | +$25.2K | 0.17% | 118 |
|
|
2024
Q1 | $3.58M | Buy |
9,853
+454
| +5% | +$149K | 0.19% | 109 |
|
|
2023
Q4 | $2.81M | Buy |
9,399
+105
| +1% | +$30.7K | 0.18% | 125 |
|
|
2023
Q3 | $2.66M | Sell |
9,294
-92
| -1% | -$26.2K | 0.18% | 121 |
|
|
2023
Q2 | $2.63M | Buy |
9,386
+48
| +0.5% | +$12.5K | 0.17% | 129 |
|
|
2023
Q1 | $2.39M | Sell |
9,338
-15
| -0.2% | -$4.37K | 0.16% | 140 |
|
|
2022
Q4 | $3.1M | Sell |
9,353
-24
| -0.3% | -$7.59K | 0.22% | 110 |
|
|
2022
Q3 | $2.6M | Sell |
9,377
-23
| -0.2% | -$6.47K | 0.2% | 114 |
|
|
2022
Q2 | $2.48M | Buy |
9,400
+313
| +3% | +$80.7K | 0.18% | 120 |
|
|
2022
Q1 | $2.18M | Buy |
9,087
+767
| +9% | +$180K | 0.13% | 162 |
|
|
2021
Q4 | $1.91M | Sell |
8,320
-332
| -4% | -$70.6K | 0.12% | 176 |
|
|
2021
Q3 | $1.73M | Buy |
8,652
+1,545
| +22% | +$336K | 0.11% | 184 |
|
|
2021
Q2 | $1.69M | Sell |
7,107
-99
| -1% | -$24.7K | 0.12% | 177 |
|
|
2021
Q1 | $1.74M | Buy |
7,206
+15
| +0.2% | +$3.34K | 0.13% | 158 |
|
|
2020
Q4 | $1.5M | Buy |
7,191
+314
| +5% | +$61.6K | 0.13% | 164 |
|
|
2020
Q3 | $1.17M | Sell |
6,877
-154
| -2% | -$27.1K | 0.11% | 182 |
|
|
2020
Q2 | $1.32M | Sell |
7,031
-94
| -1% | -$17.8K | 0.14% | 154 |
|
|
2020
Q1 | $1.26M | Buy |
7,125
+267
| +4% | +$51.8K | 0.18% | 118 |
|
|
2019
Q4 | $1.4M | Buy |
6,858
+1,207
| +21% | +$221K | 0.14% | 157 |
|
|
2019
Q3 | $858K | Sell |
5,651
-9
| -0.2% | -$1.47K | 0.09% | 217 |
|
|
2019
Q2 | $893K | Buy |
5,660
+131
| +2% | +$20.5K | 0.11% | 195 |
|
|
2019
Q1 | $889K | Buy |
5,529
+35
| +0.6% | +$6.39K | 0.12% | 180 |
|
|
2018
Q4 | $1.04M | Buy |
5,494
+148
| +3% | +$30.9K | 0.16% | 148 |
|
|
2018
Q3 | $1.11M | Hold |
5,346
| – | – | 0.14% | 170 |
|
|
2018
Q2 | $908K | Sell |
5,346
-201
| -4% | -$34.8K | 0.12% | 191 |
|
|
2018
Q1 | $930K | Buy |
5,547
+394
| +8% | +$76.6K | 0.12% | 197 |
|
|
2017
Q4 | $1.05M | Sell |
5,153
-757
| -13% | -$151K | 0.14% | 179 |
|
|
2017
Q3 | $1.11M | Hold |
5,910
| – | – | 0.16% | 153 |
|
|
2017
Q2 | $990K | Buy |
5,910
+465
| +9% | +$74.7K | 0.16% | 161 |
|
|
2017
Q1 | $797K | Sell |
5,445
-300
| -5% | -$44.2K | 0.13% | 192 |
|
|
2016
Q4 | $767K | Sell |
5,745
-100
| -2% | -$13.1K | 0.13% | 197 |
|
|
2016
Q3 | $762K | Buy |
5,845
+2,600
| +80% | +$339K | 0.13% | 192 |
|
|
2016
Q2 | $416K | Sell |
3,245
-2,767
| -46% | -$365K | 0.07% | 292 |
|
|
2016
Q1 | $825K | Hold |
6,012
| – | – | 0.15% | 173 |
|
|
2015
Q4 | $880K | Sell |
6,012
-75
| -1% | -$10.3K | 0.16% | 165 |
|
|
2015
Q3 | $822K | Buy |
6,087
+321
| +6% | +$46.6K | 0.15% | 171 |
|
|
2015
Q2 | $934K | Sell |
5,766
-15
| -0.3% | -$2.07K | 0.15% | 163 |
|
|
2015
Q1 | $749K | Buy |
5,781
+100
| +2% | +$11.6K | 0.12% | 195 |
|
|
2014
Q4 | $585K | Sell |
5,681
-5
| -0.1% | -$493 | 0.1% | 234 |
|
|
2014
Q3 | $516K | Hold |
5,686
| – | – | 0.09% | 245 |
|
|
2014
Q2 | $523K | Buy |
5,686
+400
| +8% | +$34.3K | 0.09% | 251 |
|
|
2014
Q1 | $443K | Buy |
+5,286
| New | +$435K | 0.11% | 206 |
|
Other funds holding CI
VCM
VPM
Moors & Cabot's CI Position: Q1 2026 in Review
Moors & Cabot reduced its Cigna (CI) stake by 0.97% in Q1 2026, selling an estimated $24.6K and leaving 9,124 shares worth $2.43M. The position accounts for 0.1% of the portfolio, ranked #179.
Moors & Cabot first reported a position in CI in Q1 2014 and has held it in 49 quarters since. The position peaked at $3.58M in Q1 2024. 1,655 funds tracked by Wall St. Rank hold CI as of Q1 2026.
- Moors & Cabot held 9,124 shares of Cigna worth $2.43M as of Q1 2026.
- Moors & Cabot sold 89 Cigna shares in Q1 2026, an estimated $24.6K.
- Cigna made up 0.1% of Moors & Cabot's portfolio in Q1 2026, its #179 holding.
- Moors & Cabot first reported a position in Cigna in Q1 2014 and has held it in 49 quarters since.
- Moors & Cabot's Cigna position peaked at $3.58M in Q1 2024.
- 1,655 funds tracked by Wall St. Rank held Cigna as of Q1 2026.
Based on Moors & Cabot's 13F filing for Q1 2026, filed 8 May 2026.